Week In Review: Tang Capital Offers $465 Million For LianBio Plus 80% Of Any Licenses/Divestments

LianBio received a $465 million buyout offer from Tang Capital Management. In addition, Tang also offered shareholders a contingent value right for 80% of net proceeds from any license or divestment of a LianBio holding.